Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1051-1057
Published online before print March 9, 2006, doi: 10.1161/01.ATV.0000216747.66660.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/5/1051    most recent
01.ATV.0000216747.66660.26v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibuya, T.
Right arrow Articles by Sato, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibuya, T.
Right arrow Articles by Sato, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1051.)
© 2006 American Heart Association, Inc.


Vascular Biology

Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin

Takumi Shibuya; Kazuhide Watanabe; Hiroshi Yamashita; Kazue Shimizu; Hiroki Miyashita; Mayumi Abe; Takuya Moriya; Hideki Ohta; Hikaru Sonoda; Tooru Shimosegawa; Koichi Tabayashi; Yasufumi Sato

From the Department of Vascular Biology (T.S., K.W., H.Y., K.S., H.M., M.A., Y.S.), Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan; the Department of Pathology (T.M.), Tohoku University Hospital, Sendai, Japan; Diagnostics Science Division (H.O., H.S.), Shionogi & Co, Ltd, Toyonaka, Japan; the Department of Gastroenterology (K.W., T.S.), Tohoku University Graduate School of Medicine, Sendai, Japan; and the Department of Cardiovascular Surgery (T.S.), Tohoku University Graduate School of Medicine, Sendai, Japan. Present address of Mayumi Abe: Department of Nanomedicine, Tokyo Medical and Dental University, Tokyo, Japan.

Correspondence to Yasufumi Sato, Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. E-mail y-sato{at}idac.tohoku.ac.jp

Objective— We recently isolated vasohibin, a novel vascular endothelial growth factor (VEGF)-inducible endothelium-derived angiogenesis inhibitor. Our aim is to find DNA sequences homologous to vasohibin and determine their expression profile.

Methods and Results— By the search of DNA sequences in the database, we found one homologous gene and designated it vasohibin-2. Overall amino acid sequence homology between the prototype vasohibin (vasohibin-1) and vasohibin-2 was >50%. Vasohibin-2 exhibited antiangiogenic activity. Vasohibin-2 expression in cultured endothelial cells was low and not inducible by the stimulation that induced vasohibin-1. However, the immunohistochemical analysis revealed that vasohibin-1 and -2 were diffusely expressed in endothelial cells in embryonic organs during mid-gestation. After that time point, vasohibin-1 and -2 became faint, but persisted to a certain extent in arterial endothelial cells from late gestation to neonate. Expression of vasohibin-1 and -2 could be augmented in vivo by local transfection with the VEGF gene in the embryonic brain or by cutaneous wounding in adult mice.

Conclusion— These results suggest that vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.

We found vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Vasohibin-2 exhibited antiangiogenic activity. Immunohistochemical analysis revealed that 2 vasohibins were ubiquitously expressed in endothelial cells in developing embryonic organs during mid-gestation. Vasohibin-2, in combination with vasohibin-1, forms a novel family of angiogenesis inhibitors.


Key Words: angiogenesis inhibitor • endothelial cells • vascular development • vasohibin




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
T. Hosaka, H. Kimura, T. Heishi, Y. Suzuki, H. Miyashita, H. Ohta, H. Sonoda, T. Moriya, S. Suzuki, T. Kondo, et al.
Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis
Am. J. Pathol., July 1, 2009; 175(1): 430 - 439.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Kimura, H. Miyashita, Y. Suzuki, M. Kobayashi, K. Watanabe, H. Sonoda, H. Ohta, T. Fujiwara, T. Shimosegawa, and Y. Sato
Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis
Blood, May 7, 2009; 113(19): 4810 - 4818.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Naito, H. Kidoya, Y. Sato, and N. Takakura
Induction and Expression of Anti-Angiogenic Vasohibins in the Hematopoietic Stem/Progenitor Cell Population
J. Biochem., May 1, 2009; 145(5): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Sato and H. Sonoda
The Vasohibin Family: A Negative Regulatory System of Angiogenesis Genetically Programmed in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 37 - 41.
[Abstract] [Full Text] [PDF]